Geode Capital Management’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.45M | Buy |
592,865
+294,617
| +99% | +$4.2M | ﹤0.01% | 2463 |
|
2025
Q1 | $3.87M | Buy |
298,248
+29,602
| +11% | +$384K | ﹤0.01% | 2771 |
|
2024
Q4 | $3.58M | Sell |
268,646
-4,050
| -1% | -$54K | ﹤0.01% | 2907 |
|
2024
Q3 | $1.64M | Buy |
272,696
+32,365
| +13% | +$194K | ﹤0.01% | 3191 |
|
2024
Q2 | $791K | Buy |
240,331
+6,164
| +3% | +$20.3K | ﹤0.01% | 3397 |
|
2024
Q1 | $878K | Buy |
234,167
+6,911
| +3% | +$25.9K | ﹤0.01% | 3411 |
|
2023
Q4 | $996K | Buy |
227,256
+9,627
| +4% | +$42.2K | ﹤0.01% | 3361 |
|
2023
Q3 | $908K | Buy |
217,629
+7,537
| +4% | +$31.4K | ﹤0.01% | 3365 |
|
2023
Q2 | $733K | Buy |
210,092
+23,510
| +13% | +$82.1K | ﹤0.01% | 3475 |
|
2023
Q1 | $718K | Hold |
186,582
| – | – | ﹤0.01% | 3506 |
|
2022
Q4 | $522K | Sell |
186,582
-389
| -0.2% | -$1.09K | ﹤0.01% | 3643 |
|
2022
Q3 | $392K | Hold |
186,971
| – | – | ﹤0.01% | 3856 |
|
2022
Q2 | $489K | Hold |
186,971
| – | – | ﹤0.01% | 3778 |
|
2022
Q1 | $815K | Buy |
186,971
+11,118
| +6% | +$48.5K | ﹤0.01% | 3709 |
|
2021
Q4 | $754K | Buy |
175,853
+18,737
| +12% | +$80.3K | ﹤0.01% | 3846 |
|
2021
Q3 | $791K | Buy |
157,116
+1,835
| +1% | +$9.24K | ﹤0.01% | 3810 |
|
2021
Q2 | $956K | Sell |
155,281
-110,264
| -42% | -$679K | ﹤0.01% | 3628 |
|
2021
Q1 | $1.94M | Buy |
265,545
+49,506
| +23% | +$362K | ﹤0.01% | 3262 |
|
2020
Q4 | $1.76M | Buy |
216,039
+68,212
| +46% | +$554K | ﹤0.01% | 3152 |
|
2020
Q3 | $1.17M | Buy |
147,827
+41,815
| +39% | +$330K | ﹤0.01% | 3150 |
|
2020
Q2 | $577K | Buy |
+106,012
| New | +$577K | ﹤0.01% | 3319 |
|